Quarterly report · Q2
6323.TEDINET S100PCL9
Period2022-03-01 → 2022-08-31
Filed2022-10-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥45.8bn | 2022-03-01 → 2022-08-31 | Cons. | Net sales |
| Revenue | ¥67.0bn | 2021-03-01 → 2022-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥29.5bn | 2021-03-01 → 2021-08-31 | Cons. | Net sales |
| Operating income | ¥10.9bn | 2022-03-01 → 2022-08-31 | Cons. | Operating income |
| Operating income | ¥6.7bn | 2021-03-01 → 2021-08-31 | Cons. | Operating income |
| Ordinary income | ¥16.9bn | 2022-03-01 → 2022-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥17.8bn | 2021-03-01 → 2022-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.3bn | 2021-03-01 → 2021-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥16.9bn | 2022-03-01 → 2022-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥8.2bn | 2021-03-01 → 2021-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥12.4bn | 2022-03-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥12.8bn | 2021-03-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.5bn | 2021-03-01 → 2021-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥13.0bn | 2022-03-01 → 2022-08-31 | Cons. | Profit loss |
| Net income | ¥6.2bn | 2021-03-01 → 2021-08-31 | Cons. | Profit loss |
| Total assets | ¥111.1bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥88.3bn | at 2022-02-28 | Cons. | Assets |
| Total assets | ¥72.1bn | at 2021-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥45.0bn | at 2022-08-31 | Cons. | Liabilities |
| Total liabilities | ¥38.1bn | at 2022-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥66.1bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥50.2bn | at 2022-02-28 | Cons. | Net assets |
| Net assets / equity | ¥41.7bn | at 2021-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥25.3bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥23.6bn | at 2022-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥25.3bn | at 2022-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥23.6bn | at 2022-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.8bn | at 2021-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.8bn | at 2021-02-28d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥1.2bn | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.0bn | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2021-03-01 → 2021-08-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.3bn | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥916m | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥778m | 2021-03-01 → 2021-08-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥4.9bn | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.6bn | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.1bn | 2021-03-01 → 2021-08-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥715.61 | 2022-03-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥418.97 | 2022-06-01 → 2022-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥742.1 | 2021-03-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥318.2 | 2021-03-01 → 2021-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥162.16 | 2021-06-01 → 2021-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥714.27 | 2022-03-01 → 2022-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥740.72 | 2021-03-01 → 2022-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥317.63 | 2021-03-01 → 2021-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 54.2% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.4% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.5% | at 2021-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-03-01 → 2022-08-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2022-03-01 → 2022-08-31 | −¥356m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue | 2022-03-01 → 2022-08-31 | ¥185m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue external | 2022-03-01 → 2022-08-31 | ¥185m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | segment profit | 2022-03-01 → 2022-08-31 | −¥88m |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue | 2022-03-01 → 2022-08-31 | ¥45.6bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue external | 2022-03-01 → 2022-08-31 | ¥45.6bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥0 |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | segment profit | 2022-03-01 → 2022-08-31 | ¥11.4bn |
| —segment total | revenue | 2022-03-01 → 2022-08-31 | ¥45.8bn |
| —segment total | revenue external | 2022-03-01 → 2022-08-31 | ¥45.8bn |
| —segment total | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥0 |
| —segment total | segment profit | 2022-03-01 → 2022-08-31 | ¥11.3bn |
| Reconciling Itemsreconciling | revenue | 2021-03-01 → 2021-08-31 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-03-01 → 2021-08-31 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2021-03-01 → 2021-08-31 | −¥196m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue | 2021-03-01 → 2021-08-31 | ¥244m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue external | 2021-03-01 → 2021-08-31 | ¥244m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | segment profit | 2021-03-01 → 2021-08-31 | −¥42m |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue | 2021-03-01 → 2021-08-31 | ¥29.3bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue external | 2021-03-01 → 2021-08-31 | ¥29.3bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue intersegment | 2021-03-01 → 2021-08-31 | ¥1m |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | segment profit | 2021-03-01 → 2021-08-31 | ¥6.9bn |
| —segment total | revenue | 2021-03-01 → 2021-08-31 | ¥29.5bn |
| —segment total | revenue external | 2021-03-01 → 2021-08-31 | ¥29.5bn |
| —segment total | revenue intersegment | 2021-03-01 → 2021-08-31 | ¥1m |
| —segment total | segment profit | 2021-03-01 → 2021-08-31 | ¥6.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 515
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and cash equivalents | CurrentQuarterInstant | 25303000000 | JPY |
| Directors compensations sga | Prior1YTDDuration | 137000000 | JPY |
| Directors compensations sga | CurrentYTDDuration | 251000000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 742000000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 720000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 580000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 312000000 | JPY |
| Provision for directors bonuses sga | Prior1YTDDuration | 49000000 | JPY |
| Provision for directors bonuses sga | CurrentYTDDuration | 36000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 31000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | -18000000 | JPY |
| Provision for directors retirement benefits sga | Prior1YTDDuration | 18000000 | JPY |
| Provision for directors retirement benefits sga | CurrentYTDDuration | 165000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 339000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 438000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | -13000000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | -46000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 29255000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentsMember | 244000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 29499000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 29499000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 29257000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentsMember | 244000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 29501000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -1000000 | JPY |
| Net sales | Prior1YTDDuration | 29499000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 6921000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentsMember | -42000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 6878000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -196000000 | JPY |
| Operating income | Prior1YTDDuration | 6681000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 45567000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentsMember | 185000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 45753000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 45753000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -0 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 45568000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentsMember | 185000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 45753000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |